Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: March 2009
-
March 13, 2009 – Current Strategies for Patent Claim Construction: Key Updates on Patent Prosecution and Litigation (Law Seminars International) – San Francisco, CA March 23-24, 2009 – 3rd Annual Patent Law Institute (Practising Law Institute) – San Francisco, CA March 24, 2009 – 5th Annual Document Management, E-Discovery, and Litigation Readiness for Life Sciences…
-
By Sherri Oslick — On March 2, 2009, Chile deposited its instrument of accession to the Patent Cooperation Treaty (PCT) with the World Intellectual Property Office (WIPO), becoming the 140th PCT Contracting State. The PCT will enter into force in Chile on June 2, 2009. Further information will be available in the March edition…
-
Law Seminars International (LSI) will be holding a one-day seminar on Patent Claim Construction on April 24, 2009 at the Georgia International Convention Center in College Park, GA. The seminar will address: • Current Federal Circuit cases on claim interpretation;• Creating more valuable patents and making them easier to defend;• Overall litigation strategies from plaintiff…
-
By Donald Zuhn — On Tuesday, Senator Arlen Spector (R-PA) (at right), the ranking member of the Senate Judiciary Committee, sent a letter to Committee Chairman Patrick Leahy (D-VT), requesting that the Senate patent reform bill (S. 515) "not be placed on the Executive Business Agenda until late May, after the Court of Appeals…
-
By David Boundy — A notice and comment period of great importance to the patent community opened last week, and this period is scheduled to remain open only until March 16th. This period arises as a result of a "Memorandum for the Heads of Executive Departments and Agencies" (74 Fed. Reg. 5977) issued by…
-
By Kevin E. Noonan — The Supreme Court handed down its decision in Wyeth v. Levine today, and in a 6-3 decision, declared that the labeling regulations and decisions by the Food and Drug Administration (FDA) did not preempt state tort liability based on "failure-to-warn" and strict liability theories. As Justice Alito noted (albeit…
-
By Donald Zuhn — During yesterday's press conference announcing the introduction of new patent reform legislation in both the Senate and House, Senate Judiciary Committee Chairman Patrick Leahy (D-VT) noted that the Senate Judiciary Committee would be holding a hearing on patent reform next week. The hearing, entitled "Patent Reform in the 111th Congress: …
-
By Sherri Oslick — Thrasos Therapeutics, a Hopkinton, MA based biotechnology company, announced earlier this week the issuance of U.S. Patent No. 7,482,329 ("Single Domain TDF-Related Compounds and Analogs Thereof," issued January 27, 2009) directed to small molecules that selectively activate the key receptors of the bone morphogenetic protein (BMP) family. BMPs are part…
-
By Donald Zuhn — In a joint press conference held earlier today, leaders from both the Senate and House announced the introduction of new patent reform legislation. Appearing at the conference were Senator Patrick Leahy (D-VT), the Chairman of the Senate Judiciary Committee, Senator Orrin Hatch (R-UT), Representative John Conyers (D-MI), the Chairman of…
-
By Suresh Pillai —Penwest and Endo Announce a Settlement of Opana® ER Litigation On February 20, Penwest Pharmaceuticals, based in Danbury, CT, and Endo Pharmaceuticals jointly announced a settlement of their litigation with Morristown, NJ-based Actavis South Atlantic LLC over the production and sale of generic formulations of Opana® ER (oxymorphone hydrochloride) (see "Court…
Patent Docs 